Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Depreciation & Amortization (CF) (2024 - 2026)

Carlsmed posted quarterly Depreciation & Amortization (CF) of $99000.0 for Q1 2026, up 147.5% year-on-year from $40000.0 in Q1 2025, and up 1.02% on a QoQ basis from $98000.0 in Q4 2025.

Carlsmed (CARL) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $99000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 147.5% year-over-year to $99000.0; the trailing twelve-month figure through Mar 2026 stood at $340000.0 (up 61.9% YoY), and the FY2025 full-year result was $281000.0, up 93.79% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $99000.0, up from $98000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $100000.0 in Q2 2024 and bottomed at $33000.0 in Q3 2024.
  • The 3-year median for Depreciation & Amortization (CF) is $71500.0 (2025), against an average of $68750.0.
  • Peak annual rise in Depreciation & Amortization (CF) reached 164.86% in 2025, while the deepest fall reached 39.0% in 2025.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $37000.0 in 2024, then soared by 164.86% to $98000.0 in 2025, then rose by 1.02% to $99000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $99000.0 (Q1 2026), $98000.0 (Q4 2025), and $82000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 8.32 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 39.09 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 38.21 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 1.17 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 4.13 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 41.45 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 9.96 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 146,000.00
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 18.60 Mn
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn 99,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 99,000.00
Mar 31, 2026 99,000.00
Dec 31, 2025 98,000.00
Dec 31, 2025 98,000.00
Sep 30, 2025 82,000.00
Sep 30, 2025 82,000.00
Jun 30, 2025 61,000.00
Jun 30, 2025 61,000.00
Mar 31, 2025 40,000.00
Mar 31, 2025 40,000.00
Dec 31, 2024 37,000.00
Dec 31, 2024 37,000.00
Sep 30, 2024 33,000.00
Sep 30, 2024 33,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00